GlassScriptPhysician profile
Sanjoy Bhattacharya
NPI 1710150693
$41,662.49
in general payments reported to CMS, 2019-2025
40 companies · $11K in 2025
The $11K reported for 2025 was more than what 82% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $3,460 · 2021: $1,902 · 2022: $2,906 · 2023: $2,417 · 2024: $5,064 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,600 · Food and Beverage: $7,196 · Travel and Lodging: $3,890.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,600.00 |
| Food and Beverage | $7,196.21 |
| Travel and Lodging | $3,890.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $21,178.63 | 2019-2025 | Aveir, Gallant, Ensite |
| Abbvie INC. | $9,182.40 | 2025 | |
| Medtronic, INC. | $3,375.10 | 2021-2025 | Pulseselect, Na, Micra |
| Boston Scientific Corporation | $2,521.06 | 2019-2025 | Farapulse, Watchman |
| Novartis Pharmaceuticals Corporation | $787.41 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $681.66 | 2019-2025 | Lifevest |
| Biosense Webster, INC. | $539.37 | 2024 | Carto 3 |
| Janssen Pharmaceuticals, INC | $343.96 | 2019-2023 | Xarelto |
| Medtronic Vascular, INC. | $304.97 | 2019-2020 | |
| Abiomed | $292.56 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $290.73 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $254.58 | 2020-2025 | Jardiance |
| Bardy Diagnostics, INC. | $220.00 | 2019-2022 | |
| Amgen INC. | $204.13 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $185.70 | 2021-2025 | Camzyos, Eliquis |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $143.19 | 2022-2025 | Optimizer |
| Merck Sharp & Dohme LLC | $137.32 | 2021-2023 | Verquvo |
| Amarin Pharma, INC. | $90.72 | 2019-2021 | |
| Chiesi USA, INC. | $90.21 | 2020-2021 | |
| Pfizer INC. | $81.72 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $74.66 | 2020-2021 | |
| Atricure, INC. | $74.29 | 2023 | |
| Sanofi-Aventis U.S. LLC | $71.91 | 2019-2023 | |
| Cleerly, INC. | $64.30 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Kestra Medical Technology Services, INC. | $55.34 | 2024 | Assure Wcd |
| Edwards Lifesciences Corporation | $50.61 | 2020 | |
| Zoll Respicardia, INC. | $46.49 | 2023-2024 | Remede System |
| Inspire Medical Systems, INC. | $46.11 | 2025 | Inspire |
| Novo Nordisk INC | $45.21 | 2022-2024 | Wegovy |
| Philips North America LLC | $32.16 | 2022-2023 | |
| Innovation Technologies INC | $27.95 | 2022 | |
| Baxter Healthcare | $26.20 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Cvrx, INC. | $25.25 | 2025 | Barostim Neo System |
| Itamar Medical INC | $19.35 | 2022 | |
| Alnylam Pharmaceuticals INC. | $18.56 | 2024 | Amvuttra |
| Cook Medical LLC | $16.87 | 2021 | |
| Esperion Therapeutics, INC. | $16.36 | 2022 | |
| Elutia, INC. | $15.62 | 2021 | |
| Cardiva Medical, INC. | $15.53 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Preventice Services, LLC | $14.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjoy Bhattacharya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.